IMCC Stock Overview
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
IM Cannabis Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$1.13 |
| 52 Week High | CA$1.90 |
| 52 Week Low | CA$0.24 |
| Beta | 1.9 |
| 1 Month Change | -8.13% |
| 3 Month Change | 276.67% |
| 1 Year Change | 15.31% |
| 3 Year Change | -98.05% |
| 5 Year Change | n/a |
| Change since IPO | -95.52% |
Recent News & Updates
Recent updates
Potential Upside For IM Cannabis Corp. (CSE:IMCC) Not Without Risk
Jul 19
Health Check: How Prudently Does IM Cannabis (CSE:IMCC) Use Debt?
Dec 24Don't Ignore The Fact That This Insider Just Sold Some Shares In IM Cannabis Corp. (CSE:IMCC)
Feb 05
What Percentage Of IM Cannabis Corp. (CSE:IMCC) Shares Do Insiders Own?
Jan 08Shareholder Returns
| IMCC | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | 44.9% | 4.9% | 1.1% |
| 1Y | 15.3% | 44.3% | 7.5% |
Return vs Industry: IMCC underperformed the Canadian Pharmaceuticals industry which returned 48% over the past year.
Return vs Market: IMCC exceeded the Canadian Market which returned 6.1% over the past year.
Price Volatility
| IMCC volatility | |
|---|---|
| IMCC Average Weekly Movement | 39.6% |
| Pharmaceuticals Industry Average Movement | 14.9% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CA Market | 18.2% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: IMCC's share price has been volatile over the past 3 months.
Volatility Over Time: IMCC's weekly volatility has increased from 30% to 40% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 95 | Oren Shuster | imcannabis.com |
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers medical cannabis dried flowers; and full-spectrum, strain-specific cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients.
IM Cannabis Corp. Fundamentals Summary
| IMCC fundamental statistics | |
|---|---|
| Market cap | CA$15.14m |
| Earnings (TTM) | -CA$9.50m |
| Revenue (TTM) | CA$48.80m |
0.3x
P/S Ratio-1.6x
P/E RatioIs IMCC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IMCC income statement (TTM) | |
|---|---|
| Revenue | CA$48.80m |
| Cost of Revenue | CA$38.96m |
| Gross Profit | CA$9.85m |
| Other Expenses | CA$19.34m |
| Earnings | -CA$9.50m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 08, 2024
| Earnings per share (EPS) | -0.71 |
| Gross Margin | 20.17% |
| Net Profit Margin | -19.46% |
| Debt/Equity Ratio | 91.3% |
How did IMCC perform over the long term?
See historical performance and comparison